References
- Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991; 91: 86–89.
- Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in USA hospitals: a three-year analysis. Clin Infect Dis 1999; 29: 239–244.
- Febré N, Silva V, Medeiros EA, Wey SB, Colombo AL, Fischman 0. Microbiological characteristics of yeasts isolated from urinary tracts of intensive care unit patients undergoing urinary catheter-ization. J Clin Microbiol 1999; 37: 1584–1586.
- Pfaller MA, Jones RN, Doern GV, et al. Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America,1997-1998. Ant imicrob Agents Chemother 2000; 44: 747–751.
- Pfaller MA, Diekema DJ, Jones RN, et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to flucona-zole, ravuconazole and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001; 39: 3245–3249.
- Saint-Germain G, Lavendière M, Pelletier R, et al. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of 2 years (1996 to 1998) multicenter surveillance study in Québec, Canada. J Clin Micro-biol 2001; 39: 949–953.
- Rodero L, Davel G, Cordoba S, Soria M, Cantero C, Hochenfeller F. Multicenter study on nosocomial candidiasis in the Republic of Argentina. Rev Argent Microbiol 1999; 31: 114–119.
- Yarrow D. Methods for the isolation, maintenance and identifica-tion of yeasts. In: Kurtzman CP, Fell JW, eds. The Yeasts: a Taxonomic Study, 6th edn. Amsterdam: Elsevier, 1998: 75–107.
- National Committee for Clinical Laboratory Standards. Refer-ence Method For Broth Dilution Antifungal Susceptibility Test-ing of Yeasts. Approved Standard. Document M 27-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 1997.
- Cuenca-Estrella M, Diaz-Guerra TM, Mellado E, Rodriguez-Tudela JL. Influence of glucose supplementation and inoculum size of growth kinetics and antifungal susceptibility testing of Candida spp. J Clin Microbiol 2001; 39: 525–532.
- Pfaller MA, Messer SA, Loffmann S. Comparison of visual and spectrophotometric methods of MIC endpoint determinations by using broth microdilution methods to test five antifungal agents, including the new triazole D0870. J Clin Microbiol 1995; 3: 1094–1097.
- MacDonald L, Baker C, Chenoeth C. Risk factors for candidemia in a children's hospital. Clin Infect Dis 1998; 26: 642–645.
- Nolla-Salas J, Sitges-Serra JA, Leon-Gil C, et al. Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study group of fungal infections in ICU. Intensive Care Med 1997; 23: 23–30.
- Sanven P, Bevanger L, Digranes A, et al. Constant low rate of fungemia in Norway, 1991 to 1996. J Clin Microbiol 1998; 36: 3455–3459.
- Colombo AL. Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective. Braz J Infect Dis 2000; 3: 113–118.